VVTMF (VVT Med) 12-1 Month Momentum %: N/A% (As of Aug. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VVTMF VVT Med Inc VVTMF
2 GF Score
Price $0.16
! 5 Warning Signs
View Full Analysis

What is VVT Med 12-1 Month Momentum %?

VVT Med VVTMF 2 12-1 Month Momentum % is N/A% as of Aug. 20, 2026. GuruFocus rates VVTMF with a GF Score™ of 2/100. The stock has 5 warning signs investors should review. Among 824 Medical Devices & Instruments companies, VVT Med ranks worse than 74.27% on this metric.

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-08-20), VVT Med's 12-1 Month Momentum % is N/A%.

The industry rank for VVT Med's 12-1 Month Momentum % or its related term are showing as below:

VVTMF's 12-1 Month Momentum % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -19.085
* Ranked among companies with meaningful 12-1 Month Momentum % only.

VVT Med  (OTCPK:VVTMF) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

VVT Med 12-1 Month Momentum % Related Terms

VVTMF
2GF Score
VVT Med Inc VVTMF
12-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

VVT Med  (OTCPK:VVTMF) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 12-1 Month Momentum % →
What does a 12-1 Month Momentum % of N/A% mean?
VVT Med (VVTMF) has a 12-1 Month Momentum % of N/A% as of Aug. 20, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on VVT Med and its competitors. According to the industry distribution chart, VVT Med ranks #612 out of 824 companies in the Medical Devices & Instruments industry, placing it in the top 74.3%.
Is VVT Med's 12-1 Month Momentum % too high?
VVT Med's current 12-1 Month Momentum % is N/A%. Based on the distribution chart, VVT Med ranks #612 out of 824 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, VVT Med has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does VVT Med's 12-1 Month Momentum % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, VVT Med ranks #612 out of 824 companies for 12-1 Month Momentum %. This places VVT Med in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Medical Devices & Instruments company?
A good 12-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on VVT Med and its competitors. VVT Med's current 12-1 Month Momentum % is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VVT Med stock overvalued right now?
VVT Med (VVTMF) has a current 12-1 Month Momentum % of N/A%. The current 12-1 Month Momentum % is N/A%. VVT Med's overall GF Score™ is 2/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For VVT Med (VVTMF), the current 12-1 Month Momentum % is N/A% as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

VVT Med Business Description

Other Exchanges VVTM:Canada
Address 700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8
VVT Med Inc is a medical device company, focused on developing and commercializing a range of minimally invasive technologies for treating varicose veins. VVT's research and development activities are based in Israel. The company proudly boasts three products within its portfolio that have achieved commercial production status and are currently available in the market. These products have undergone meticulous design processes, obtaining regulatory approvals across multiple countries.
2GF Score

Get the complete analysis for VVTMF

12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.16
Price